Albumedix Media News & Events How Vaccines are Changing the World 2022

How Vaccines are Changing the World 2022

26 Apr 2022

Highlighting the manufacture and distribution of albumin, a biological product that is helping to address critical issues in the development, production and formulation of life-saving vaccines.

Collaboration in the Vaccine Industry.

Developing a vaccine, or any therapeutic for that matter, takes a long time and attrition rates are steep. There are many points in which a vaccine can fail. Close collaboration across the industry can facilitate solutions to critical problems and ensure more vaccines reaches patients.

Read more about how you can overcome your vaccine challenges by using our albumin.

CONTACT

Albumedix Ltd.
Mabel Street
The Meadows
Nottingham
NG2 3ED, United Kingdom
Tel: +44 115 9553379
info@albumedix.com

 

Albumedix - Dedicated to Better Health

Albumedix is a science-driven company and recognized leader of best-in-class albumin-enabled solutions. Established in the UK in 1984, with a mission to empower excellence, Albumedix has supported its life-science partners to deliver hundreds of million safe doses of clinical and marketed therapeutics, globally. Albumedix’ solutions include the world’s only USP-NF compliant recombinant human albumin (Recombumin®), client-centric development and compliance services and drug-enhancing technologies (Veltis®). By always striving for more and collaboratively challenging status quo, Albumedix enables the development and commercialisation of advanced therapies and next-generation biopharmaceuticals to the benefit of people worldwide.

 

Privacy | Cookies | Patent Portfolio

ALBUMEDIX, the ALBUMEDIX LOGO, DEDICATED TO BETTER HEALTH and marks such as RECOMBUMIN and VELTIS are trademarks of Albumedix. Albumedix© Copyright 2018

FOLLOW US